Skip to main content
Austar Lifesciences Limited logo

Austar Lifesciences Limited — Investor Relations & Filings

Ticker · 6118 ISIN · KYG0632L1023 HKEX Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6118

About Austar Lifesciences Limited

http://www.austar.com.hk

Austar Lifesciences Limited provides integrated engineering solutions, equipment, services, and consumables to pharmaceutical manufacturers and research institutes in the life sciences sector. The company delivers turnkey solutions focused on quality, compliance, and operational excellence, utilizing extensive expertise in process technology and regulatory practices. Core offerings include specialized systems for bioprocessing, clean utilities, pharmaceutical preparation, aseptic freeze-drying, filling, visual inspection, clean room environments, and automation control. Products span Bioprocess Equipment, Clean Utility Equipment & Chemical Pharmaceutical Preparation Systems, and Pharmaceutical Process Contamination Control Products, ensuring comprehensive support for complex manufacturing and research needs.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-05 English
NOTIFICATION LETTER WITH REQUEST FORM TO NON-REGISTERED SHAREHOLDER(S)
Regulatory Filings
2026-04-23 English
NOTIFICATION LETTER WITH REPLY FORM TO REGISTERED SHAREHOLDERS
Report Publication Announcement Classification · 87% confidence The document is a notification letter to registered shareholders informing them that the 2025 Annual Report, circular, proxy form and ESG report have been published and are available online. It does not contain the actual financial statements or report content, but merely announces their publication and distribution options. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA), not the report itself.
2026-04-23 English
2025 Environmental, Social and Governance Report
Environmental & Social Information Classification · 95% confidence The document is a comprehensive Environmental, Social and Governance (ESG) report titled “ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025” for Austar Lifesciences, covering ESG management approach, stakeholder engagement, environmental and social performance metrics, and governance framework. This matches the definition for “Environmental & Social Information” (Code: SR) – a report detailing the company’s performance on ESG factors.
2026-04-23 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice convening the Annual General Meeting of Austar Lifesciences Limited, setting out the ordinary and special resolutions to be voted on (director re-elections, auditor appointment, share issuance and repurchase mandates, amendments to the articles, etc.), along with proxy appointment instructions. This is not the full annual report or any financial statements themselves but the shareholder meeting notice and proxy solicitation materials. Under our taxonomy, this aligns with Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
Form of Proxy for Use at the Annual General Meeting (or at Any Adjournment thereof)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Form of Proxy for the Annual General Meeting, meant to be sent to shareholders to solicit their voting instructions before the meeting. This falls under Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to request votes for meetings.
2026-04-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.